HealthTech Opportunities in Brazil: Webinar

On April 22, 2020, swissnex Brazil held the webinar HealthTech Opportunities in Brazil, for Swiss healthcare startups, especially those focused on diagnostics technologies and interested in learning how to start an innovative business in Brazil. To help entrepreneurs to overcome the initial lack of information about the Brazilian ecosystem, an open innovation specialist at one of Brazil’s major private healthcare providers and a regulatory expert will address market opportunities, the macroeconomic scenario, and answer questions.

According to the guest speakers, Brazil offers great opportunities for Swiss HealthTech startups. As Claire Bottero mentioned, there are many opportunities for these startups in Brazil, especially in the Biotech sector. However startups with a viable and ready-to-go to market product are more likely to receive attention from venture capitalists in Brazil. A partnership with DASA (Diagnosticos da Américas S.A.) would also be interesting as they have a big presence in Brazil and in Latin America and would fasten the expansion of the products to neighboring countries.

Despite companies having to face a complex regulatory environment, Marco Aurelio notes that registering a product in Brazil has advantages. One of them being the fact that ANVISA (Brazil’s Health Regulatory Agency) is part of the MDSAP (Medical Device Single Audit Program) which satisfies the requirements of multiple regulatory jurisdictions (Australia, Canada, Japan, and the US). This means that a product approved in Brazil could be marketed in the aforementioned countries.

Startups based in Switzerland that are thinking about internationalisation should consider INNOSUISSE Internationalisation Camps. These can be held in different countries and would be tailored to the needs of the startup, and they usually include conferences, workshops and meetings with local partners. You can find more information about the camp in Brazil here or get in touch with Amanda Akemi, our Startup and Innovation Program Manager.

Claire Bottero
Pharmaceutical with post-graduation in investments and strategy from ESSEC Business School, Claire is responsible for the Scouting and Strategy part for clinical and genomic analysis at Dasa. She is also the focal point of Cubo Health, Latin America’s biggest innovation hub.

Marco Aurelio 
Partner in TozziniFreire’s Life Sciences and Healthcare practice group, Marco Aurélio has broad experience in regulatory matters and administrative health regulatory proceedings. He assists clients in several sectors of the industry on consulting and administrative procedures, especially before ANVISA (Brazilian Health Regulatory Agency) and MAPA (Brazilian Ministry of Agriculture, Livestock, and Food Supply). He acts in matters related to the licensing and registration of products subject to health surveillance, new technologies, the launch of new products in the Brazilian market, and drug recall.


Watch the recording of the webinar bellow: